Polymer industries are continuously substituting metals, glass, paper, and other traditional materials in various applications due to their lightweight, strength, and design flexibility along with low-cost. The demand for polymers is driven by growth in end-use markets, such as packaging, building & construction, consumer goods, horticulture, automotive, rail transport, electronics, and telecommunications. But, current manufacturing practices and disposal processes of polymers create a highly polluting environment affecting air, water, and soil quality index.
As a leading silicone product manufacturer, Ami Polymer has adequately maintained eco-friendly processing techniques according to ISO 14001 guidelines ensuring the least impact of atmospheric areas within and surrounding the premises. “As silicones are one of the finest choices of the medical and pharma industry, undoubtedly its consumption is huge annually. Single-use practices of silicone products are now popularizing among pharma industries, which has created the scope of brainstorming on reusability/recyclability of the same. Yet the journey has begun and we expect to team up very soon on biodegradable versions of pharma & medical industry polymers”, said Alpesh Gandhi, MD, Ami Polymer.
Founded in 1996, Ami Polymer is headquartered in Mumbai. The company has always looked upon offering unique products to its clients, which has gradually earned customers' satisfaction.
This is because the company has focused on product quality and efficiency in order to fulfill the needs of the customers within the promised delivery date. Ami procures the expectational quality raw materials from reputed suppliers and makes sure that the quality is optimum by their in-house laboratory set-ups. Secondly, the key to success for Ami Polymer is flexibility. The company offers products according to customers’ demands, providing an exceptional level of customization in development with a quick problem-solving approach. Ami’s core strength is high standard certifications of regulatory standards like USFDA, UK MHRA, EU-GMP, AUSTRALIA-TGA, HEALTH CANADA. The company is also having the best team of rubber technology professionals and management professionals recruited from premier institutes of India.
Furthermore, Ami Polymer is the first and only Indian silicone product offering company with successful implementations of stringent extractable study programs through worldclass Toxikon USA Lab. The company provides brands like pharma tubing, pharma hoses, inflatable seals, tri-clover gaskets, etc. They are tested for food and pharma grade toxicity standards to ensure risk-free operations pharma and biopharma industries. The company offers almost 5000+ product varieties from multiple MOCs like Silicone, TPE, Fluoroplastics, EPDM, NBR, CR, FKM, which are designed for food, pharma, biopharma, medical, heavy engineering industries. Ami is also a popular choice among critical service sectors of PSU projects. Ami can provide such remarkable products because of highly profiled technical officials and enthusiastic professionals who have been dedicatedly placing their efforts to maintain exponential growth of the organization.
Ami’s core strength is high standard certifications of regulatory standards like USFDA, UK MHRA, EUGMP, AUSTRALIA-TGA, HEALTH CANADA
Currently, the firm has 3000+ clients globally with 5000+ products offering range. Reputed companies like Baxter, Pfizer, Mylan, Dr.Reddy’s laboratory, Zydus Cadila, Mankind pharma, etc. have audited Ami Polymer’s cleanroom premises for the supply of critical products used in the manufacturing of life-saving drugs. However, shortly, the company has been dedicatedly focusing on importing substitute-based high-quality products for food, pharma, and biopharma industries. Ami Polymer is planning to expand the manufacturing facility to multiply the capacity of production and certifying facility and products through renowned agencies of world. Ami is also focusing on expanding product distribution networks in Asia, Europe, and the USA. Additionally, Ami Polymer is planning to launch an ISO 13485 compliant medical division facility to manufacture critical human implants.